Ophthalmic Viscosurgical Devices (OVD) Market Size By Product (Dispersive, Cohesive, Combined), By Application (Cataract Surgery, Vitreoretinal Surgery, Canaloplasty, Refractive Surgery, Keratoplasty), By End-use (Hospitals, Clinics), Industry Analysis Report, Regional Outlook (U.S., Canada, Germany, UK, France, Spain, Italy, Japan, China, India, Australia, Malaysia, Brazil, Mexico, Argentina, South Africa, Saudi Arabia), Application Potential, Competitive Market Share & Forecast, 2018 - 2024

Latest Update: Dec 2018 |  Published Date: Jan 2017 | Report ID: GMI1134 | Authors: Sumant Ugalmugale, Rupali Swain Report Format: PDF

  Request Sample
Summary Table of Contents Industry Coverage Methodology

Industry Trends

Ophthalmic Viscosurgical Devices (OVD) Market size was valued at USD 353.0 million in 2017 and is expected to witness 12.3% CAGR from 2018 to 2024.

U.S. Ophthalmic viscosurgical devices market, by product, 2017 & 2024 (USD Million)
U.S. Ophthalmic viscosurgical devices market, by product, 2017 & 2024 (USD Million)

Get more details on this report - Request Free Sample PDF

Increasing prevalence of ophthalmic diseases coupled with rapidly growing diabetes burden worldwide is the key factor driving ophthalmic viscosurgical devices industry growth. According to the World Health Organization report, more than 285 million people worldwide have vision impairment, and 42% due to uncorrected refractive errors. Furthermore, myopia is estimated to affect half of the global population by 2050. Such factors will surge the demand for technologically advanced eye surgeries thereby, augmenting OVD industry growth. Moreover, growing geriatric population base, advancements in healthcare infrastructure and rising healthcare expenditure will further drive business growth.

Technological advancements in ophthalmic surgeries will positively impact OVD business growth in coming years. Increasing patient preference towards non-invasive and advanced treatments such as laser-assisted vision correction surgeries such as LASIK will spur OVD market size in coming years. However, high costs coupled with risks associated with eye surgeries may hamper industry growth to certain extent in developing and under developed countries. Post operational risks associated with ophthalmic surgeries including visual aberrations, development of chronic dry and red eyes, over or under-correction of vision and infection may impact negatively on OVD industry growth. 

Ophthalmic Viscosurgical Devices Market, By Product

Dispersive OVDs segment accounted for USD 170.2 million revenue in 2017 and is expected to show significant growth in the foreseeable future. Surgeries such as dense cataracts, requiring significantly greater amounts of fluid flow and ultrasound energy within the eye, have potential to traumatize the cornea. Growing adoption of dispersive OVDs to protect corneal endothelium from ultrasonic waves during such surgeries will accelerate segmental growth.

Cohesive OVDs segment is projected to show robust CAGR of 12.5% during the forecast timeline. Demand for cohesive OVDs for inflating capsular bag prior to lens implantation will increase its adoption in various surgical procedures. Growing usage of cohesive OVDs for creating and maintaining space in anterior segment of the eye during surgery will further spur segment size in coming years.

Germany Ophthalmic Viscosurgical Devices Market Size, By Product, 2017 (USD Million)
Germany Ophthalmic Viscosurgical Devices Market Size, By Product, 2017 (USD Million)

Get more details on this report - Request Free Sample PDF


Ophthalmic Viscosurgical Devices Market, By Application

Refractive surgery segment was valued at USD 34.0 million revenue in 2017 and will witness robust growth over the forecast period. Surge in the number of people affected by myopia will lead to refractive disorders thereby, escalating demand for refractive surgery. According to International Myopia Institute (IMI), an average 30% of the global population is currently affected by myopia, and the number is projected to reach 50% by 2050. Moreover, availability of technologically advanced refractive surgery devices such as excimer lasers and femtosecond lasers will further favour segmental growth.

Vitreoretinal surgery segment will witness lucrative CAGR of 12.6% during the analysis timeframe owing to rising prevalence of vitreous and retinal diseases across the globe. According to British and Eire Association of Vitreoretinal Surgeons (BEAVRS) about 50% of the patients requiring vitreoretinal surgery are emergency cases including eye trauma and retinal detachment. Increasing prevalence of sight threatening conditions such as macular hole, epiretinal membrane and diabetic retinopathy will propel segment growth in coming years.

Ophthalmic Viscosurgical Devices Market, By End-use

Hospitals segment held significant revenue share of 44.8% in 2017 and is estimated to grow during the forecast period. Segmental growth is attributable to growing disease burden across the globe. Availability of high-tech equipment and technologies in hospital settings will surge the number of surgeries being performed thereby augmenting business growth.

Clinics segment was valued at USD 123.8 million in 2017 and will witness significant growth by 2024. Increasing number of cataract procedures in developed and developing countries will favour segmental growth. High adoption rate of advanced ophthalmic devices required in various minimally invasive Lasik procedures should escalate segmental growth over the forthcoming years.

Ophthalmic Viscosurgical Devices Market, By Region

North America OVD market dominated the global market with 48.8% revenue share in 2017 and is expected to witness similar trend over analysis period. High growth is attributed to rising incidence of ophthalmic diseases such as visual impairment and blindness, refractive errors and eye injuries in the region. According to American Academy of Ophthalmology’s Eye Health Statistics, cataract affects around 24.4 million Americans aged 40 years and above whereas glaucoma affects over 2.7 million in 2015. Increasing prevalence of such diseases will spur North America OVD market size over the forecast period.

Asia Pacific OVD market is estimated to show lucrative CAGR of 14.6% over the forecast timeline attributable to rising prevalence of diabetes in the region. Growing prevalence of diabetic eye diseases including diabetic retinopathy, cataract, diabetic macular edema (DME), and others will render positive impact on the regional growth.

Asia Pacific Ophthalmic Viscosurgical Devices Market Size, By Country, 2024 (USD Million)
Asia Pacific Ophthalmic Viscosurgical Devices Market Size, By Country, 2024 (USD Million)

Get more details on this report - Request Free Sample PDF

Competitive Market Share

Some of the prominent industry players operational in ophthalmic viscosurgical devices market include Alcon, Amring Pharmaceuticals, Bausch & Lomb, Bohus Biotech, Carl Zeiss Meditec, CIMA Technology, Johnson & Johnson Surgical Vision, Maxigen Biotech, Precision Lens, Rayner Intraocular Lenses and Sidapharm. Major industry players are primarily focusing on strategies including new product launch, mergers, acquisition and collaborations to strengthen existing product portfolio and capitalize on market share. For instance, in October 2018, Carl Zeiss announced agreement to acquire IanTech that is a firm focused in technological solutions for micro interventional cataract surgeries.

Ophthalmic Viscosurgical Devices (OVD) Industry Background

Ophthalmic Viscosurgical Devices (OVD) Market Segmentation

Get more details on this report - Request Free Sample PDF

Discovery and development of ophthalmic viscosurgical devices can be dated back to 1934, when hyaluronic acid was isolated as the substance of the vitreous body of human eye. Sodium hyaluronate, the first substance used as an OVD and is now the most commonly used material for ophthalmic viscosurgical devices used in eye surgeries. The first licensed OVD, Healon (sodium hyaluronate 1%), was developed in 1979 by Pharmacia. Healon was launched and became commercially available by 1980 and received U.S. FDA approval in 1983. Later, an international standard for the safety, performance and approval requirements for viscoelastics was developed under a new designation of ophthalmic viscosurgical devices (OVDs). Since the introduction of Healon, OVDs have become an essential tool in various ophthalmic surgeries such as anterior segment surgery. Introduction of OVDs had an influence on the evolution of phacoemulsification and extracapsular surgery such as reduction in incidence of corneal edema. Thus, OVDs have a great impact on the success of intraocular lens implantation and cataract surgery. Today, use of OVDs have substantially increased for cornea, cataract, trauma, glaucoma and vitreoretinal surgeries. Thus, ophthalmic viscosurgical devices industry is projected to witness lucrative growth in the coming years.

What Information does this report contain?

Historical data coverage: 2013 to 2017; Growth Projections: 2018 to 2024.
Expert analysis: industry, governing, innovation and technological trends; factors impacting development; drawbacks, SWOT.
6-7 year performance forecasts: major segments covering applications, top products and geographies.
Competitive landscape reporting: market leaders and important players, competencies and capacities of these companies in terms of production as well as sustainability and prospects.

Premium Report: Details

Pages: 145
Tables: 172
Charts / Figures: 8
Companies covered: 11
Countries covered: 17

Special Requests?

Inquire Before Buying
This site is protected by Trustwave's Trusted Commerce program Authorize.Net Merchant - Click to Verify BBB Rating - Click to Verify

15% Free Customization
Share your Requirements

Customize this Report

Questions? Speak to an Analyst

Full Name *
Email *
Phone (With Country Code)
Message *
Are you human?
0 + 4 =

Your personal details are secure. Privacy Policy

Connect with our sales team

Chat With Us
We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies. More info. I Agree